Stay updated on SAGE-217 Efficacy in Major Depressive Disorder Clinical Trial
Sign up to get notified when there's something new on the SAGE-217 Efficacy in Major Depressive Disorder Clinical Trial page.

Latest updates to the SAGE-217 Efficacy in Major Depressive Disorder Clinical Trial page
- CheckyesterdayChange DetectedThe two screenshots show the same NCT03672175 study page with only minor formatting and layout differences; there are no changes to core content such as study design, outcomes, enrollment, or status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check30 days agoChange DetectedAdded a prominent operating-status notice and updated the system version to v3.2.0, replacing the previous v3.1.0.SummaryDifference2%

- Check37 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.0%

- Check52 days agoChange DetectedUpdated to revision v3.0.2 and removed the Back to Top element.SummaryDifference0.1%

- Check59 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.1%

- Check66 days agoChange DetectedThe web page has added a facility name and location, along with a significant reference to a clinical study on zuranolone in major depressive disorder, while removing various location-related terms and previous revision information.SummaryDifference1%

Stay in the know with updates to SAGE-217 Efficacy in Major Depressive Disorder Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAGE-217 Efficacy in Major Depressive Disorder Clinical Trial page.